Kitani Tomoya 木谷友哉

… Alternative Names

KITANI Tomoya 木谷友哉

Less

Researcher Number	30842257
Other IDs	https://orcid.org/0000-0002-2696-046X
Affiliation (Current)	2026: 京都府立医科大学, 大学院医学研究科, 助教
Affiliation (based on the past Project Information) *help	2022 – 2025: 京都府立医科大学, 医学(系)研究科(研究院), 助教 2019 – 2021: 京都府立医科大学, 医学部附属病院, 専攻医
Review Section/Research Field	Principal Investigator Basic Section 53020:Cardiology-related / 0902:General internal medicine and related fields
Keywords	Principal Investigator 心筋細胞 / 心不全 / 多能性幹細胞 / 必須遺伝子 / 拡張不全型心不全 / 心臓線維芽細胞 / 心筋線維芽細胞 / ヒトiPS細胞 / 心筋脂肪 / ヒト多能性幹細胞由来心筋細胞 … More / CRISPR/Cas9 / 細胞死 / ヒト多能性幹細胞 / iPS細胞 / CRISPRスクリーニング / ゲノム編集 Less

Identification of Therapeutic Targets Based on Human cardiac Gene Expression for the Development of Innovative Heart Failure TreatmentsPrincipal Investigator
- Principal Investigator
  
  木谷友哉
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Targeting myocardial essential genes to develop novel therapeutic approaches against heart failurePrincipal Investigator
- Principal Investigator
  
  Kitani Tomoya
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Discovery of Therapeutic Targets for Heart Failure with Preserved Ejection Fraction using CRISPR/Cas9 Technology and Human Pluripotent Stem Cells.Principal Investigator
- Principal Investigator
  
  Kitani Tomoya
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
循環microRNAとヒト多能性幹細胞を用いた拡張型心不全の病態解明Principal Investigator
- Principal Investigator
  
  木谷友哉
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53020:Cardiology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Discovery of novel molecular mechanism to promote human cardiomyocytes survivalPrincipal Investigator
- Principal Investigator
  
  KITANI Tomoya
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0902:General internal medicine and related fields
- Research Institution
  Kyoto Prefectural University of Medicine

All 2025 2024 2023 2022 2020

All Journal Article Presentation

[Journal Article] Thousand and one amino acid protein kinase 1 suppression improves doxorubicin-induced cardiomyopathy by preventing cardiomyocyte death and dysfunction2025
- Author(s)
  Suga Takaomi、Kitani Tomoya、Kogure Masaya、Oishi Masatsugu、Ito Fumiaki、Hoshino Atsushi、Ogata Takehiro、Ikeda Koji、Matoba Satoaki
- Journal Title
  
  Cardiovascular Research
  
  Volume: in press Issue: 4 Pages: 601-613
- DOI
  10.1093/cvr/cvaf022
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] TAOK1 Suppression Mitigates Cardiomyocyte Death and Improves Cardiac Function in Heart Failure Models2025
- Author(s)
  小暮雅哉、木谷友哉
- Organizer
  XXV ISHR World Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] Inhibition of TAOK1-mediated Cardiomyocyte Death Attenuates Doxorubicin-Induced Cardiotoxicity2024
- Author(s)
  Masaya Kogure, Tomoya Kitani
- Organizer
  Basic Cardiovascular Sciences Scientific Sessions 2024.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] Inhibition of TAOK1-mediated cardiomyocyte death attenuates doxorubicin-induced cardiotoxicity2024
- Author(s)
  菅孝臣、木谷友哉
- Organizer
  第72回日本心臓病学会学術集会
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] Uncovering Mechanisms and Therapeutic Targets for Cardiovascular Disease Using Human Cardiomyocytes Derived from Pluripotent Stem Cells2024
- Author(s)
  木谷　友哉
- Organizer
  第88回日本循環器学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] CRISPR-Cas9 Kinase Screening Identifies TAOK1 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity2024
- Author(s)
  菅孝臣、木谷友哉
- Organizer
  第88回日本循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] Targeting TAOK1 prevents cardiomyocyte death and cardiac dysfunction induced by doxorubicin via inhibiting the p38-MAPK signaling pathway2023
- Author(s)
  木谷　友哉
- Organizer
  2023年度日本心脈管作動物質学会若手研究者交流シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-23K15105
[Presentation] CRISPR-Cas9 Screen in Human Pluripotent Stem Cell-derived Cardiomyocytes Reveals Therapeutic Target for Doxorubicin-induced Cardiac Dysfunction2022
- Author(s)
  Tomoya Kitani
- Organizer
  第26回日本心不全学会総会
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022
- Author(s)
  木谷　友哉
- Organizer
  国際心臓研究学会日本部会総会
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022
- Author(s)
  Tomoya Kitani
- Organizer
  39th Annual Meeting of the ISHR-Japanese Section
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] A CRISPR Screen in Human Pluripotent Stem Cell-Derived Cardiomyocytes Identifies a Novel Therapeutic Target for Doxorubicin-induced Cardiotoxicity2022
- Author(s)
  Tomoya Kitani
- Organizer
  66th Annual Scientific Meeting of The Korean Society of Cardiology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K16030
[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022
- Author(s)
  木谷　友哉
- Organizer
  国際心臓研究学会日本部会総会
- Data Source
  KAKENHI-PROJECT-19K23950
[Presentation] Cardiovascular Disease Modeling and Translational Research Using Human induced Pluripotent Stem Cells: Opportunity and Challenge2020
- Author(s)
  木谷　友哉
- Organizer
  2020 International Conference of Korean Society for Molecular and Cellular Biology
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K23950

1. 的場聖明 (10305576)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Kitani Tomoya 木谷 友哉

KITANI Tomoya 木谷 友哉

Research Projects

Research Products

Co-Researchers

Identification of Therapeutic Targets Based on Human cardiac Gene Expression for the Development of Innovative Heart Failure TreatmentsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Targeting myocardial essential genes to develop novel therapeutic approaches against heart failurePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Discovery of Therapeutic Targets for Heart Failure with Preserved Ejection Fraction using CRISPR/Cas9 Technology and Human Pluripotent Stem Cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

循環microRNAとヒト多能性幹細胞を用いた拡張型心不全の病態解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Discovery of novel molecular mechanism to promote human cardiomyocytes survivalPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Thousand and one amino acid protein kinase 1 suppression improves doxorubicin-induced cardiomyopathy by preventing cardiomyocyte death and dysfunction2025

Author(s)

Journal Title

DOI

Data Source

[Presentation] TAOK1 Suppression Mitigates Cardiomyocyte Death and Improves Cardiac Function in Heart Failure Models2025

Author(s)

Organizer

Data Source

[Presentation] Inhibition of TAOK1-mediated Cardiomyocyte Death Attenuates Doxorubicin-Induced Cardiotoxicity2024

Author(s)

Organizer

Data Source

[Presentation] Inhibition of TAOK1-mediated cardiomyocyte death attenuates doxorubicin-induced cardiotoxicity2024

Author(s)

Organizer

Data Source

[Presentation] Uncovering Mechanisms and Therapeutic Targets for Cardiovascular Disease Using Human Cardiomyocytes Derived from Pluripotent Stem Cells2024

Author(s)

Organizer

Data Source

[Presentation] CRISPR-Cas9 Kinase Screening Identifies TAOK1 Suppression Ameliorates Doxorubicin-Induced Cardiotoxicity2024

Author(s)

Organizer

Data Source

[Presentation] Targeting TAOK1 prevents cardiomyocyte death and cardiac dysfunction induced by doxorubicin via inhibiting the p38-MAPK signaling pathway2023

Author(s)

Organizer

Data Source

[Presentation] CRISPR-Cas9 Screen in Human Pluripotent Stem Cell-derived Cardiomyocytes Reveals Therapeutic Target for Doxorubicin-induced Cardiac Dysfunction2022

Author(s)

Organizer

Data Source

[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022

Author(s)

Organizer

Data Source

[Presentation] Disease Modeling and Translational Research for Cancer Therapeutics-Related Cardiac Dysfunction using Human Pluripotent Stem Cells2022

Author(s)

Organizer

Data Source

[Presentation] A CRISPR Screen in Human Pluripotent Stem Cell-Derived Cardiomyocytes Identifies a Novel Therapeutic Target for Doxorubicin-induced Cardiotoxicity2022

Author(s)

Organizer

Data Source

Kitani Tomoya 木谷友哉

KITANI Tomoya 木谷友哉